The C4orf46 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-mediated gene-edited polyclonal cell population derived from the near-haploid human HAP1 cell line. This product features a targeted disruption of the C4orf46 gene, generated using a ribonucleoprotein-based CRISPR/Cas9 approach to introduce loss-of-function modifications across a heterogeneous pool of knockout cells. The polyclonal format preserves cellular diversity, enabling robust screening applications where gene function is interrogated in a mosaic population that better reflects physiological complexity compared to monoclonal isolates. As a knockout model, it provides a powerful tool for dissecting the biological roles of C4orf46 without the influence of clonal selection artifacts.
The host HAP1 cell line is a near-haploid, fibroblast-like derivative of the KBM-7 chronic myeloid leukemia line, originally isolated from a patient in blast crisis. Its predominantly haploid karyotype??except for a disomic chromosome 8??greatly simplifies genetic studies, as disruption of a single allele can result in near-complete loss of function. HAP1 cells are widely adopted for functional genomics and high-throughput knockout screening due to their stable growth characteristics, ease of genetic manipulation, and compatibility with a broad range of molecular and cellular assays. This genetic simplicity makes them an ideal chassis for studying poorly characterized genes such as C4orf46, where phenotypic effects may be subtle and require a sensitized background for detection.
C4orf46, located on chromosome 4, remains an uncharacterized gene with no validated molecular function, interacting partners, or associated signaling pathways. Preliminary computational and transcriptional data suggest a potential involvement in cellular differentiation or proliferation, but specific mechanisms are unknown. As no upstream regulators, downstream targets, or representative pathway components have been experimentally confirmed, its role in signaling networks remains speculative. The knockout of C4orf46 in a reductionist system like HAP1 offers a clean background to probe its function, free from the confounding complexity of redundant paralogs or compensatory pathways often present in diploid models, thus enabling the identification of subtle phenotypes that may be masked elsewhere.
The introduction of C4orf46 disruption into HAP1 cells creates a valuable model for functional annotation studies. In cancer biology contexts, HAP1??s hematopoietic origin and transformed nature provide relevant insights into genes that may modulate proliferation or viability in leukemic settings. The knockout population can be analyzed for growth rate alterations, cell cycle distribution changes, colony-forming efficiency, and response to metabolic or genotoxic stress. Because the polyclonal pool contains a spectrum of editing outcomes, it supports pooled screening approaches where the relative fitness of knockout cells can be assessed under selective conditions, thereby linking C4orf46 to particular cellular processes without prior mechanistic assumptions.
This polyclonal knockout product is well-suited for diverse research applications including functional genomics, CRISPR knockout screening, and cancer cell biology studies. Representative experimental workflows include RT-qPCR and western blotting to confirm target gene disruption and assess compensatory protein expression, cell viability assays (e.g., MTT, CellTiter-Glo) to measure proliferative capacity, colony formation assays to evaluate anchorage-dependent growth, and RNA-seq for transcriptome-wide profiling of gene expression changes upon C4orf46 loss. The cells can also serve as negative controls in interaction studies or as a starting material for synthetic lethality screens. For further information or technical support, please contact Ascent Research.
